Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELIEF: Pirfenidone for Progressive Non-IPF Lung Fibrosis
DRKS00009822Phase 2Terminated
- Sponsor
- Justus Liebig University Giessen
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in fibrotic interstitial pneumonia (FIP) and Chronic respiratory conditions due to inhalation of chemicals, gases, fumes and vapors comparing Pirfenidone with Placebo (2 arms). Started Jan 2016; status: terminated.
02
Drugs
pirfenidone
03
Conditions
fibrotic interstitial pneumonia (FIP)Chronic respiratory conditions due to inhalation of chemicals, gases, fumes and vapors
Beyond the preview
Go deeper on DRKS00009822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00009822.